Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis

被引：0
|
作者：
Calzetta, L. [1 ]
Cavalli, F. [2 ]
Chetta, A. [1 ]
Cazzola, M. [2 ]
Rogliani, P. [2 ]
机构：
[1] Univ Parma, Parma, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Asthma; Pharmacology; Treatments;
D O I：
10.1183/13993003.congress-2022.294
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
294
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study
    Boulet, Louis -Philippe
    Abbott, Carl
    Brusselle, Guy
    Edwards, Dawn
    Oppenheimer, John
    Pavord, Ian D.
    Pizzichini, Emilio
    Sagara, Hironori
    Slade, David
    Wechsler, Michael E.
    Gibson, Peter G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (05): : 1244 - 1253.e8
  • [42] Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    CHEST, 2019, 155 (06) : 1158 - 1165
  • [43] A Randomized, Noninferiority Trial Comparing ICS thorn LABA with ICS plus LABA plus LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study
    Park, So-Young
    Kim, Solmi
    Kim, Jung-Hyun
    Kim, Sae-Hoon
    Lee, Taehoon
    Yoon, Sun-Young
    Kim, Min-Hye
    Moon, Ji-Yong
    Yang, Min-Suk
    Jung, Jae-Woo
    Kim, Joo-Hee
    Choi, Jeong-Hee
    Park, Chan Sun
    Kim, Sujeong
    Lee, Jaechun
    Kwon, Jae-Woo
    Hur, Gyu Young
    Kim, Sang-Ha
    Kim, Hee-Kyoo
    Shin, Yoo Seob
    Kim, Sang-Hoon
    Nam, Young-Hee
    Jang, An-Soo
    Park, Seo Young
    Kim, Tae-Bum
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1304 - +
  • [44] Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
    Plaza, Vicente
    Dominguez-Ortega, Javier
    Gonzalez-Segura Alsina, Diego
    Lo Re, Daniele
    Sicras-Mainar, Antoni
    PHARMACEUTICALS, 2023, 16 (11)
  • [45] Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile
    Calzetta, Luigino
    Ludovica Ritondo, Beatrice
    de Marco, Patrizia
    Cazzola, Mario
    Rogliani, Paola
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (04) : 579 - 581
  • [46] ASSESSING ALGORITHMS TO IDENTIFY ASTHMA PATIENTS USING MULTIPLE INHALER TRIPLE THERAPY (COMPRISING ICS, LABA, LAMA) IN A REAL-WORLD DATABASE
    Meeraus, W.
    Numbere, B.
    Liu, Y.
    Czira, A.
    Zhang, W.
    VALUE IN HEALTH, 2022, 25 (01) : S271 - S271
  • [47] A Brief Report on a Systematic Review of Real-World Effectiveness Studies of ICS/LAMA/LABA for Treatment of Adults with Asthma in the US
    Noorduyn, Stephen G.
    Begaj, Kejsi
    Martin, Amber
    Forero-Schwanhaeuser, Sergio
    Schaible, Kassandra
    Moore, Alison
    Paczkowski, Rosirene
    PULMONARY THERAPY, 2025,
  • [48] CT Mucus Score Predicts Response to 6-weeks ICS/LABA/LAMA in Moderate Asthma
    Tcherner, S.
    Mozaffaripour, A.
    Kooner, H. K.
    Sharma, M.
    Mcintosh, M.
    Aseffa, Y.
    Paul, N.
    Yamashita, C.
    Parraga, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [49] Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    CHEST, 2020, 158 (02) : 832 - 833
  • [50] Rapid and Persistent 6-week Response to ICS/LABA/LAMA in Mild-moderate Asthma
    Sharma, M.
    Kooner, H. K.
    Tcherner, S.
    Mozaffaripour, A.
    Paul, N.
    Yamashita, C.
    Parraga, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345